A study of brepocitinib in adults with active non-infectious non-anterior uveitis
The company Priovant Therapeutics, Inc is enrolling patients into the clinical trial investigating A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis (NEPTUNE).
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with active intermediate, posterior, or pan non-infectious uveitis (NIU).
The trial is designed to enroll male and female 18 Years to 74 Years and is being conducted in the California Eye Specialists Medical Group, Inc, Pasadena, California, United States; Texas Retina Associates, Plano, Texas, United States.
The study start date is September 2022.
This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT05523765.
